{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:08:07Z","timestamp":1790759287362,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We examined trends in the incidence rates of invasive cervical cancer (<jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content>) and in the rate of survival after <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> among women living with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content>) in France and compared them to those of the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Histologically validated incident cases of <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> in the period 1992\u20132009 from the French Hospital Database on <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">FHDH<\/jats:styled-content>\u2010ANRS CO4) were included in the study. Age\u2010standardized incidence rates were estimated for <jats:styled-content style=\"fixed-case\">FHDH<\/jats:styled-content> and the general population in France for 1992\u20131996 [pre\u2010combination antiretroviral therapy (<jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content>) period], 1997\u20132000 (early <jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content> period), 2001\u20132004 (intermediate <jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content> period), and 2005\u20132009 (late <jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content> period). Age\u2010standardized incidence ratios (<jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content>s) were calculated. Five\u2010year survival was compared with that of the general population for <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> diagnosed in 2005\u20132009 after standardization for age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 28\u00a0977 <jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content>, 60 incident <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content>s were histologically validated. There was a nonsignificant decreasing trend for the incidence across the <jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content> periods (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.07), from 60 to 36\/100\u00a0000 person\u2010years. The risk of <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> was consistently significantly higher in <jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content> than in the general population; the <jats:styled-content style=\"fixed-case\">SIR<\/jats:styled-content> was 5.4 [95% confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) 3.0\u20138.9] during the pre\u2010<jats:styled-content style=\"fixed-case\">cART<\/jats:styled-content> period and 3.3 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 2.2\u20134.7) in 2005\u20132009. Survival after <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> did not improve across periods (log\u2010rank <jats:italic>P<\/jats:italic>\u00a0=\u00a00.14), with overall estimated 5\u2010year survival of 78% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.67\u20130.89%). Five\u2010year survival was similar for <jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content> and the general population for women diagnosed with <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> in 2005\u20132009, after standardization (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.45).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ICC risk is still more than three times higher in <jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content> than in the general population. Survival after <jats:styled-content style=\"fixed-case\">ICC<\/jats:styled-content> did not improve over time and was similar to that of the general population during the most recent period. Such results call for promotion of the uptake of screening in <jats:styled-content style=\"fixed-case\">WLHIV<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12703","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T04:15:09Z","timestamp":1548735309000},"page":"222-229","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Invasive cervical cancer in <scp>HIV<\/scp>\u2010infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on <scp>HIV<\/scp> (<scp>FHDH<\/scp>)\u2013Agence Nationale de Recherches sur le SIDA et les H\u00e9patites Virales (<scp>ANRS) CO<\/scp>4 cohort study"],"prefix":"10.1111","volume":"20","author":[{"given":"S.","family":"Grabar","sequence":"first","affiliation":[{"name":"Sorbonne University INSERM IPLESP (Pierre Louis Institute of Public Health) Paris France"},{"name":"Unit of Biostatistic and Epidemiology Assistance Publique\u2010H\u00f4pitaux de Paris (AP\u2010HP) Paris Centre University Hospitals Paris Descartes University Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hleyhel","sequence":"additional","affiliation":[{"name":"CERIPH Center for Research in Public Health Pharmacoepidemiology Surveillance Unit Faculty of Public Health Lebanese University Fanar Lebanon"},{"name":"INSPECT\u2010LB National Public Health Institute Clinical Epidemiology and Toxicology Faculty of Public Health Lebanese University Fanar Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belot","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Hospices Civils de Lyon Lyon France"},{"name":"Department of Chronical Diseases and Trauma Institute de Veille Sanitaire Saint\u2010Maurice France"},{"name":"Laboratory of Biometry and Evolutive Biology Health\u2010Biostatistics team CNRS UMR 5558 Villeurbanne France"},{"name":"Department of Non\u2010Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine Cancer Survival Group Faculty of Epidemiology and Population Health London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.\u2010M.","family":"Bouvier","sequence":"additional","affiliation":[{"name":"INSERM UMR 1231 Burgundy Digestive Cancer Registry FRANCIM Dijon University Hospital Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tattevin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Medical Reanimation Rennes University Hospital Pontchaillou Hospital Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pacanowski","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases AP\u2010HP Saint Antoine University Hospital Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Genet","sequence":"additional","affiliation":[{"name":"Hematology and AIDS Department Argenteuil Hospital Argenteuil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pradier","sequence":"additional","affiliation":[{"name":"Department of Public Health Nice University Hospital L'Archet Hospital Nice France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Salmon","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases Paris Centre University Hospitals AP\u2010HP Paris Descartes University Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Simon","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Piti\u00e9 Salp\u00eatri\u00e8re University Hospital AP\u2010HP Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pourcher","sequence":"additional","affiliation":[{"name":"INSERM U1136 AP\u2010HP Department of Infectious Diseases Piti\u00e9 Salp\u00eatri\u00e8re \u2010 Charles Foix University Hospital Sorbonne University Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010P.","family":"Spano","sequence":"additional","affiliation":[{"name":"Medical Oncology Department Piti\u00e9 Salp\u00eatri\u00e8re University Hospital AP\u2010HP IPLESP Sorbonne University INSERM Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Poizot\u2010Martin","sequence":"additional","affiliation":[{"name":"Clinical Immuno\u2010Hematology Department Aix\u2010Marseille University Sainte\u2010Marguerite University Hospital Marseille France"},{"name":"Inserm U912 (SESSTIM\u2010Health Economic and Social Sciences and Medical Informatics) Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Costagliola","sequence":"additional","affiliation":[{"name":"Sorbonne University INSERM IPLESP (Pierre Louis Institute of Public Health) Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1","article-title":"1993 Revised classification system for Hiv infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","author":"Centers for Disease Control and Prevention","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_8_3_1","unstructured":"FerlayJ SoerjomataramI ErvikMet\u00a0al.GLOBOCAN 2012:Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2012 v1.0. IARC CancerBase No. 11."},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9613"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001765"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30149-2"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25153"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-10-200805200-00005"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23487"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/424883"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000163"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr076"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit497"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30866"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000164033.02947.e3"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5967"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu002"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","unstructured":"Cowppli\u2010BonyA UhryZ RemontetLet\u00a0al.Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989\u20102013. \u00c9tude \u00e0 partir des registres des cancers du r\u00e9seau Francim. 2016.","DOI":"10.1016\/j.respe.2016.06.084"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31828177d7"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000382"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24067"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25903"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30125-X"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001765"},{"key":"e_1_2_8_26_1","unstructured":"Haut Conseil de Sant\u00e9 Publique.Vaccination contre les infections \u00e0 papillomavirus humains. Donn\u00e9es actualis\u00e9es. Haut Conseil de Sant\u00e9 Publique ; July 10th 2014."},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0000000000001664","article-title":"Gynecologic cancer in HIV\u2010infected women: treatment and outcomes in a multi\u2010institutional cohort","volume":"32","author":"Levinson KL","year":"2018","journal-title":"AIDS"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-017-0171-4"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2017.05.018"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001367"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24007"},{"key":"e_1_2_8_32_1","first-page":"80","article-title":"Cancer screening uptake among people living with HIV followed\u2010up in hospital settings in metropolitan France. Results from the Anrs\u2010Vespa2 survey, 2011","volume":"6","author":"Tron L","year":"2016","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12703","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12703","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.12703","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12703","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T12:45:51Z","timestamp":1694004351000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1111\/hiv.12703"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12703","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"2018-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}